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with septal bulging into the RV, with potential for asymmetric changes in leaflet tethering.
The potential implications are for TR repair, including relief by alleviating LV remodeling.
8:45 a.m.
868-2 Cardiovascular Risk Factors and Outcomes in Patients 
With Definite Endocarditis: The International 
Collaboration on Endocarditis – Prospective Cohort 
Study
Christopher H. Cabell, Stamatios Lerakis, Christine Selton-Suty, Andrew Wang, Vance G. 
Fowler, Jr., Gilbert Habib, Carlos Mestres, Juan Carlos Pare, Yvette Bernard, Arnold 
Bayer, Elias Abrutyn, Bruno Hoen, Jose M. Miro, G. Ralph Corey, Gail Peterson, The ICE 
Investigators, Duke Clinical Research Institute, Durham, NC
Background: A large international, prospective study of patients with IE has not been
done.
Aim of Study: To determine the clinical findings, complications, and outcomes in patients
with IE utilizing the International Collaboration on Endocarditis (ICE) Prospective Cohort
Study (ICE-PCS).
Methods: ICE-PCS began enrollment 1 January 2000. Through 15 November 2002,
1024 cases of definite IE were enrolled by 34 centers representing 15 countries. Each
center utilized a standard case report form.
Results: The median age of the cohort was 57.0 years (IQR 43.0-71.0) and 67.3% of the
patients were male. The most common co-morbidities included dialysis dependence
(10.0%), diabetes (16.6%), and IV drug use (10.8%). Preceding dental procedures were
less common (7.9%) than other invasive procedures (18.7%). Other risk factors for IE
included: previous IE (12.0%), congenital heart disease (13.1%), and underlying valvular
heart disease (36.0%). The most common organisms were Staphylococcus aureus
(32.4%), viridans group streptococci (13.1%), and Enterococcus faecalis (10.6%). Vege-
tations were documented by echocardiography in 868 patients (84.9%) Valve involve-
ment was as follows: aortic (40.6%), mitral (49.1%), tricuspid (15.1%), and pulmonic
(1.3%). Surgery during the acute episode was common (45.2%) with regurgitation
(67.0%) and heart failure (41.3%) the most frequent indications. Complications of IE
were frequent: embolic events (stroke 16.7%, other emboli 22.7%), heart failure (31.3%),
intracardiac abscess (16.2%), and death (19.4%). In the univariate analyses the stron-
gest predictors of death were: age, diabetes, hemodialysis, chronic indwelling intrave-
nous catheters, stroke, heart failure, and intracardiac abscess (p<0.001 for all). The
causative microorganisms with the highest mortality were as follows: coagulase negative
staphylococci (26.0%), Staphylococcus aureus (24.2%) and Enterococci (21.1%)
(p=0.002 for all).
Conclusion:. Even in the modern era of antimicrobial therapy and sophisticated surgical
techniques, patients with IE during the initial hospitalization remain at significant risk for
both serious complications and death.
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868-3 Comparison of Left Ventricular Sphericity and Papillary 
Muscle Tethering in the Mechanism of Ischemic Mitral 
Regurgitation in Patients With Inferior Myocardial 
Infarction
Takeshi Uemura, Yutaka Otsuji, Toshiro Kumanohoso, Kunitsugu Takasaki, Toshinori 
Yuasa, Kenichi Nakashiki, Bo Yu, Akira Kisanuki, Shinichi Minagoe, Robert A. Levine, 
Chuwa Tei, Kagoshima University, Kagoshima, Japan, Massachusetts General Hospital, 
Boston, MA
Background: Spherical left ventricle (LV) causes outward displacement of papillary mus-
cles (PMs) to induce leaflet tethering and ischemic mitral regurgitation (MR). However,
ischemic PM elongation can potentially attenuates effects of increased LV sphericity on
the ischemic MR, resulting in relatively weak relation between LV sphericity and severity
of MR.
Methods: In 50 consecutive patients with previous inferior MI, LV volume, LV ejection
fraction, mitral annular area, PM tethering distance, LV sphericity (LV short to long axis
dimension ratio in the apical 2-chamber view) and MR fraction were quantified by 2-
dimensional and Doppler echocardiography.
Results: 1) LV sphericity had significant but only fair correlation with % MR fraction (r2
=0.30, p=0.001) due to multiple patients with ischemic PM elongation and only modest
MR despite spherical LV. 2) In contrast, medial PM tethering distance had better correla-
tion with %MR fraction (r2 =0.69, p<0.001).
Conclusion: In the genesis of ischemic MR, LV sphericity, as opposed to tethering dis-
tance, is an indirect determinant, which can be affected by ischemic PM elongation.
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868-4 Natural History of Insignificant Mitral Regurgitation 
Following Aortic Valve Replacement for Degenerative 
Aortic Valve Disease
Shalini Sharma, Padmini Varadarajan, Ramdas G. Pai, Loma Linda University Medical 
Center, Loma Linda, CA
Background: Mitral regurgitation (MR) is common in patients with denerative aortic valve
disease (AVD). Though the natural history following aortic valve replacement (AVR) of
significant accompanying MR is known, that of normal or nearly normal mitral valve func-
tion is uncertain.
Methods: One hundred and forty-seven patients who had AVR for degenerative AVD and
<2+ MR (on a 1-4 scale) on a preoperative echocardiogram were followed up for a mean
of 489 days with a second echocardiogram. Patient characteristics: age 63+13 years,
69% male, EF 50+16%, 65% had CABG. Reason for AVR was severe aortic stenosis in
54% and mixed aortic valve disease in the rest. Development of 3 or 4+ MR was related
to clinical, operative and echocardiographic variables.
Results: On the follow-up echocardiogram 3 or 4+ MR developed in 25 (17%) patients: 1
(2%) of the 44 patients with no preoperative MR, 8 of the 54 (15%) patients with 1+ pre-
operative MR and 16 (33%) of the 49 patients with 2+ preoperative MR. Risk factors for
the development of 3-4+ MR included female gender (p=0.05), greater age (68+11 vs
62+14 years, p=0.03), presence of left main disease (24 vs 10%, p=0.05) and greater
degree of preoperative MR (grade 1.6+0.6 vs 0.9+0.8, p<0.0001). Reduction in LV size
(p=0.08) following AVR was marginally protective.
Conclusion: 1) Significant (3-4+) MR may develop de novo over an intermediate term fol-
low-up in up to 33% of patients undergoing AVR. 2) Risk factors for its development
include female gender, older age, presence of left main disease and greater degrees of
preoperative MR. 3) Precise mechanism of its genesis and medical and surgical strate-
gies to its prevention need further investigations.
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868-5 Effects of Ramipril on Left Ventricular Size, Mitral 
Regurgitation Severity, Exercise Time, and Quality of 
Life in Asymptomatic Patients With Mitral Regurgitation
Kevin M. Harris, Charles F. Carey, Karen Bachnick, Betsy Wilson, Kristi Goertz, 
Minneapolis Heart Institute Foundation, Minneapolis, MN, Washington University School 
of Medicine, St. Louis, MO
There is no proven medical treatment for asymptomatic chronic mitral regurgitation (MR)
which progresses over time to a symptomatic state. Small studies have offered conflicting
results regarding the use of ace-inhibition. We assessed the effects of ramipril in asymp-
tomatic patients with chronic moderate to severe MR over a 6 month interval.
Methods: We assessed the effects of ramipril (5 mg bid) on 24 patients (mean age 49 +
15 years ) with moderate to severe MR. Echocardiographic assessment of MR severity
and left ventricular (LV) size were assessed at baseline and at 6 months. Exercise time,
neurohormonal levels and the Minnesota Living with Heart Failure score (MNLHF) were
also assessed.
Results: Systolic blood pressure was lower ( 133 ± 23 vs 123 ±15, mm HG , p=0.04) at a
mean f/u of 188 days. LV cavity size was similar as assessed by LV diastolic size (5.4 ±
0.5 vs 5.3 ± 0.6cm, P=NS) and LV end systolic volume index (21 ± 8 vs 21 ± 8 ml/m2,
p=NS). There was a trend towards reduction in effective regurgitant orifice (45 ± 4 vs 33
± 3 mm2, p=NS) but no change in MR as % of left atrial area (35 vs 36% , p=NS). There
was no change in exercise time (585 ± 219 seconds vs 583 ± 200 , p=NS) or MNLHF
scores (10 ±11 vs 10 ± 9, p=NS) . There was additionally no change in atrial natiuretic
factor (50 ± 51vs 56 ± 46, p=NS), or norepinephrine (247 ± 112 vs 258 ± 76, p=NS).
Conclusions: Treatment of patients with MR with ace inhibition over a 6 month interval
did not result in a significant reduction in LV cavity size or MR severity. We noted no sig-
nificant change in exercise time, neurohormone levels or quality of life score despite a
lower SBP at f/u. Further study will be needed to determine if there is a role for ace inhi-
bition in selected patients with mitral regurgitation.
